BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3173756)

  • 1. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
    Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
    Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].
    Bayerdörffer E; Mannes GA; Pfaller P; Sauerbruch T
    Internist (Berl); 1989 Jun; 30(6):390-2. PubMed ID: 2668217
    [No Abstract]   [Full Text] [Related]  

  • 3. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative evaluation of the efficacy of complex anti-ulcer therapy and monotherapy].
    Grigor'ev PIa; Khar'kovskiĭ NN; Elina NA; Iakovenko EP
    Sov Med; 1984; (2):100-1. PubMed ID: 6719194
    [No Abstract]   [Full Text] [Related]  

  • 5. A combination of pirenzepine and cimetidine: a new approach to treatment of duodenal ulcer in "non-responders".
    Dal Monte PR; D'Imperio M; Ferri M; Fratucello F; del Soldato P
    Hepatogastroenterology; 1985 Jun; 32(3):126-8. PubMed ID: 3839484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A cimetidine-pirenzepine combination in the treatment of patients with duodenal ulcer resistant to therapy with cimetidine or ranitidine. Our experience in 22 cases].
    Capretti PG; Montalto C; Turi V; Gianni E; Marcolli G
    Minerva Dietol Gastroenterol; 1988; 34(1):31-7. PubMed ID: 3386862
    [No Abstract]   [Full Text] [Related]  

  • 7. Newer drugs in the treatment of peptic ulcer.
    Tandon BN
    Trop Gastroenterol; 1985; 6(4):188-92. PubMed ID: 3913076
    [No Abstract]   [Full Text] [Related]  

  • 8. Healing and relapse rates of duodenal ulcer with various H2 receptor antagonists.
    Ahmed W; Qureshi H; Zuberi SJ
    J Pak Med Assoc; 1988 Dec; 38(12):319-22. PubMed ID: 3148760
    [No Abstract]   [Full Text] [Related]  

  • 9. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effective drugs and less effective drugs in the treatment of duodenal ulcer].
    Ligny G; Van Cauter J
    Acta Gastroenterol Belg; 1984; 47(6):569-75. PubMed ID: 6100349
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
    Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
    Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer.
    Giacosa A; Cheli R; Molinari F; Parodi MC
    Scand J Gastroenterol Suppl; 1982; 72():215-9. PubMed ID: 6291138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Famotidine versus cimetidine in the treatment of non-complicated duodenal ulcer. A multicenter study].
    de Jesús Villalobos J; Vargas F; Arroyo de Anda R; Barrera A; Centeno F; Angel Córdova J; Marín E; Moreno J; Peña F; Saénz V
    Rev Gastroenterol Mex; 1988; 53(1):7-13. PubMed ID: 3287575
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of qid and bd administration of De-Nol in the short term treatment of duodenal ulcer.
    Lazzaroni M; Petrillo M; Bianchi Porro G
    Br J Clin Pract; 1989 Apr; 43(4):151-5. PubMed ID: 2590626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
    Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.
    Vantrappen G; Schuurmans P; Rutgeerts P; Janssens J
    Scand J Gastroenterol Suppl; 1982; 80():23-30. PubMed ID: 6761849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of the efficacy of De-Nol and ranitidine in treating duodenal ulcer].
    Oproiu A; Pospai D; Cociaşu S; Oproiu C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(4):375-84. PubMed ID: 2905519
    [No Abstract]   [Full Text] [Related]  

  • 18. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
    Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
    Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute therapy of duodenal ulcer. Comparison of famotidine and ranitidine in a single evening dose].
    Kimmig JM
    Fortschr Med; 1987 Feb; 105(5):72-6. PubMed ID: 3549493
    [No Abstract]   [Full Text] [Related]  

  • 20. [Famotidine in the therapy and prevention of duodenal ulcer].
    Reggio D; Frattaroli FM; Trentino P; Oddi A; Marzullo A; Ponsioen C; Pappalardo G
    Clin Ter; 1988 Oct; 127(2):105-11. PubMed ID: 2976345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.